DeepADAR

Drug discovery and biotech · by Deep Genomics

A model that designs guide RNAs (gRNAs) to induce ADAR-mediated editing across various trinucleotide contexts; trained to predict endogenous ADAR editing based on local sequence and structure, and fine-tuned on synthetic gRNA screening data to predict gRNA-driven editing.

What it does

A model that designs guide RNAs (gRNAs) to induce ADAR-mediated editing across various trinucleotide contexts; trained to predict endogenous ADAR editing based on local sequence and structure, and fine-tuned on synthetic gRNA screening data to predict gRNA-driven editing.

  • AI-driven drug discovery
  • Molecular design
  • Target biology discovery
  • RNA therapeutic development
Category
Drug discovery and biotech
Built for
Media and entertainment
Users
Pharmaceutical companies, Drug discovery teams
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Deep Genomics doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Deep Genomics. Ask for audit reports before you buy.

  • Administrative safeguards
  • Technical safeguards
  • Physical safeguards
  • Need-to-know access restriction
  • Record retention processes

Reviews

No reviews yet

Reviews come from people who use DeepADAR at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim DeepADAR